 |
||||
|
||||
|
||||
|
||||
Previous Article | Next Article
The Journal of Neuroscience, February 15, 2003, 23(4):1237
Cyclin-Dependent Kinase Activity Is Required for Apoptotic Death But Not Inclusion Formation in Cortical Neurons after Proteasomal Inhibition
Hardy J. Rideout1, Qiaohong Wang1, David S. Park3, and Leonidas Stefanis1, 2 Departments of 1 Neurology and 2 Pathology, Columbia University, New York, New York 10032, and 3 Neuroscience Research Institute, University of Ottawa, Ottawa, ON K1H 8M5 Canada
Growing evidence suggests that the proteasome may be dysfunctional in a number of neurodegenerative disorders, including Lewy body diseases. We have reported previously that application of pharmacological inhibitors of the proteasome to cultured cortical neurons leads to apoptotic death and formation of ubiquitinated cytoplasmic inclusions. A number of cell cycle regulatory proteins are known to be degraded by the proteasome. In light of the emerging role of aberrant cell-cycle activation in neuronal cell death, we have assessed the involvement of cell-cycle components in the effects induced by proteasomal inhibitors in cortical neurons. Death and mitochondrial dysfunction induced by lactacystin and other pharmacological inhibitors of the proteasome were prevented by flavopiridol, a specific inhibitor of cyclin-dependent kinases (Cdks). Molecular expression of the Cdk inhibitors p16 or p27, or of dominant-negative Cdk2, Cdk4, or Cdk6 was also protective against lactacystin-induced death. Flavopiridol blocked the induction of retinoblastoma protein (pRb) phosphorylation that occurred after lactacystin application, and expression of a mutant pRb that lacked phosphorylation sites was neuroprotective. These results suggest that in cortical neurons, proteasomal inhibition leads to a cell death pathway that is dependent on Cdk activation and pRb inactivation. Although cyclins D1 and E were sequestered within the ubiquitinated inclusions formed at late time points after lactacystin application, the formation of ubiquitinated inclusions was unaffected by Cdk inhibition. This suggests that there are parallel pathways regulating neuronal death and inclusion formation elicited by proteasomal inhibition in cortical neurons.
Key words: cell cycle; retinoblastoma; proteasome; apoptosis; flavopiridol; ubiquitin
Copyright © 2003 Society for Neuroscience 0270-6474/03/2341237-09$05.00/0
This article has been cited by other articles:
Y. R. Gonzalez, Y. Zhang, D. Behzadpoor, S. Cregan, S. Bamforth, R. S. Slack, and D. S. Park
CITED2 Signals through Peroxisome Proliferator-Activated Receptor-{gamma} to Regulate Death of Cortical Neurons after DNA Damage
J. Neurosci., May 21, 2008; 28(21): 5559 - 5569.
[Abstract] [Full Text] [PDF]
H. Akashiba, Y. Ikegaya, N. Nishiyama, and N. Matsuki
Differential Involvement of Cell Cycle Reactivation between Striatal and Cortical Neurons in Cell Death Induced by 3-Nitropropionic Acid
J. Biol. Chem., March 7, 2008; 283(10): 6594 - 6606.
[Abstract] [Full Text] [PDF]
X. Li, C. Peng, L. Li, M. Ming, D. Yang, and W. Le
Glial Cell-Derived Neurotrophic Factor Protects Against Proteasome Inhibition-Induced Dopamine Neuron Degeneration by Suppression of Endoplasmic Reticulum Stress and Caspase-3 Activation
J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2007; 62(9): 943 - 950.
[Abstract] [Full Text] [PDF]
G. U. Hoglinger, J. J. Breunig, C. Depboylu, C. Rouaux, P. P. Michel, D. Alvarez-Fischer, A.-L. Boutillier, J. DeGregori, W. H. Oertel, P. Rakic, et al.
The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease
PNAS, February 27, 2007; 104(9): 3585 - 3590.
[Abstract] [Full Text] [PDF]
I. S. Han, T. B. Seo, K.-H. Kim, J.-H. Yoon, S.-J. Yoon, and U. Namgung
Cdc2-mediated Schwann cell migration during peripheral nerve regeneration
J. Cell Sci., January 15, 2007; 120(2): 246 - 255.
[Abstract] [Full Text] [PDF]
Y. Zhang, D. Qu, E. J. Morris, M. J. O'Hare, S. M. Callaghan, R. S. Slack, H. M. Geller, and D. S. Park
The Chk1/Cdc25A Pathway as Activators of the Cell Cycle in Neuronal Death Induced by Camptothecin.
J. Neurosci., August 23, 2006; 26(34): 8819 - 8828.
[Abstract] [Full Text] [PDF]
H. Levkovitch-Verbin, R. Dardik, S. Vander, Y. Nisgav, M. Kalev-Landoy, and S. Melamed
Experimental glaucoma and optic nerve transection induce simultaneous upregulation of proapoptotic and prosurvival genes.
Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2491 - 2497.
[Abstract] [Full Text] [PDF]
Q. Ding, E. Dimayuga, W. R. Markesbery, and J. N. Keller
Proteasome inhibition induces reversible impairments in protein synthesis
FASEB J, June 1, 2006; 20(8): 1055 - 1063.
[Abstract] [Full Text] [PDF]
S. C. Biswas, D. X. Liu, and L. A. Greene
Bim Is a Direct Target of a Neuronal E2F-Dependent Apoptotic Pathway
J. Neurosci., September 14, 2005; 25(37): 8349 - 8358.
[Abstract] [Full Text] [PDF]
B. Tremper-Wells and M. L. Vallano
Nuclear Calpain Regulates Ca2+-dependent Signaling via Proteolysis of Nuclear Ca2+/Calmodulin-dependent Protein Kinase Type IV in Cultured Neurons
J. Biol. Chem., January 21, 2005; 280(3): 2165 - 2175.
[Abstract] [Full Text] [PDF]
H. J. Rideout, P. Dietrich, Q. Wang, W. T. Dauer, and L. Stefanis
{alpha}-Synuclein Is Required for the Fibrillar Nature of Ubiquitinated Inclusions Induced by Proteasomal Inhibition in Primary Neurons
J. Biol. Chem., November 5, 2004; 279(45): 46915 - 46920.
[Abstract] [Full Text] [PDF]
M. Zhang, J. Li, P. Chakrabarty, B. Bu, and I. Vincent
Cyclin-Dependent Kinase Inhibitors Attenuate Protein Hyperphosphorylation, Cytoskeletal Lesion Formation, and Motor Defects in Niemann-Pick Type C Mice
Am. J. Pathol., September 1, 2004; 165(3): 843 - 853.
[Abstract] [Full Text] [PDF]
C. Wojcik and M. Di Napoli
Ubiquitin-Proteasome System and Proteasome Inhibition: New Strategies in Stroke Therapy
Stroke, June 1, 2004; 35(6): 1506 - 1518.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|